On the basis of V. cholerae strain P16064, serogroup O139, spontaneous and transposon mutants with the stable lose of the capacity for producing the polysaccharide capsule, but retaining antigen O139, have been obtained. As revealed in this study, capsular and noncapsular strains differ in their sensitivity to cholera phages 20 and Inaba, as well as in agglutination with O139-antiserum. These data make it possible to use of bacteriophages for the differentiation of capsular and noncapsular strains. The use of noncapsular mutants ensure obtaining rabbit O139-antisera with higher antibody titer.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Case report: Detection of non-O1/non-O139 in a patient with hepatic space-occupying lesions using metagenomic next-generation sequencing.
Front Med (Lausanne)
November 2024
Changsha KingMed Diagnostics Group Co., Ltd., Changsha, Hunan, China.
Article Synopsis
- The study focuses on cholera infections, specifically rare cases linked to hepatic space-occupying lesions, and highlights the effectiveness of metagenomic sequencing (mNGS) for accurate pathogen identification.
- A 75-year-old man experienced diarrhea and fever after eating crabs, leading to the discovery of a liver abscess, which was diagnosed as a non-O1/O139 cholera infection through mNGS and PCR.
- The case underscores the potential of mNGS to diagnose challenging infections that other traditional methods may miss, paving the way for better clinical outcomes.
Non-O1/non-O139 Vibrio cholerae bacteraemia and cholangitis: an unusual case in an oncological patient in Lecco Hospital, Italy.
New Microbiol
November 2024
Infectious Diseases Unit, "Alessandro Manzoni" Hospital, ASST-Lecco, Lecco, Italy.
Only toxigenic serogroups O1 and O139 Vibrio cholerae have been associated with widespread cholera epidemics. Other serogroups (non-O1/non-O139 Vibrio cholerae or NOVC) most often cause sporadic gastrointestinal manifestations. Rarely, NOVC can result in severe extraintestinal manifestations in immunocompromised hosts.
View Article and Find Full Text PDFDiversity and Complexity of CTXΦ and Pre-CTXΦ Families in from Seventh Pandemic.
Microorganisms
September 2024
National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Changbai Road 155, Changping District, Beijing 102206, China.
CTXΦ is a lysogenic filamentous phage that carries the genes encoding cholera toxin (), the main virulence factor of . The toxigenic conversion of environmental strains through CTXΦ lysogenic infection is crucial for the emergence of new pathogenic clones. A special allelic form of CTXΦ, called pre-CTXΦ, is a precursor of CTXΦ and without .
View Article and Find Full Text PDFCase report: Characterization and bioinformatics analysis of non-O1/O139 strain isolated from a choledochoduodenal fistula patient with septicemia.
Front Med (Lausanne)
October 2024
Department of Infectious Diseases, People's Hospital of Xiushan County, Xiushan, China.
The gram-negative bacterium (VC) is divided into multiple serogroups, with groups O1 and O139 responsible for cholera. Conversely, belonging to the non-O1/non-O139 group (NOVC) does not produce cholera-causing toxins. Insufficient understanding of the frequency of NOVC causes fear during the early detection phase.
View Article and Find Full Text PDFChallenges and Considerations in Selecting Animal Models for Evaluating a Live, Cold-Chain-Free, Dual-Use Vaccine (MyChol) for Diarrhoeal Diseases: A Comprehensive Review.
Malays J Med Sci
October 2024
Centre of Excellence for Vaccine Development (CoEVD), AIMST University, Kedah, Malaysia.
Diarrhoeal diseases are the second leading cause of death for children under 5 years old in 69 low- and middle-income countries, with an annual economic burden of US$ 4 billion and over 525,000 lives lost. Cholera and enterotoxigenic (ETEC) traveller's diarrhoea are major diarrhoeal diseases caused by (O1 and O139 serogroups) and ETEC, which have similar pathogeneses and can co-infect. There is no exclusive vaccine for ETEC, but cholera vaccines containing the cholera toxin B (CT-B) component offer short-term cross-protection.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!